Share Price and Basic Stock Data
Last Updated: December 19, 2025, 4:22 am
| PEG Ratio | -9.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ambani Organics Ltd operates in the organic chemicals sector, a niche that has historically shown resilience amidst market fluctuations. The company reported a market capitalization of ₹81.3 Cr, with a current share price of ₹106. Over the last few years, revenue trends have exhibited volatility. For instance, sales peaked at ₹132 Cr for FY 2023 but showed a slight increase to ₹136 Cr in FY 2024, indicating a potential stabilization after a few challenging years. The company’s quarterly sales figures for the first half of FY 2025 show a promising upward trajectory, with ₹74 Cr and ₹82 Cr reported for March and September 2024, respectively. This trend could signal a recovery and renewed interest from buyers, especially considering the industry’s overall growth potential. However, the company must maintain this momentum to ensure sustained investor confidence.
Profitability and Efficiency Metrics
When analyzing profitability, Ambani Organics presents a mixed picture. The operating profit margin (OPM) stood at a modest 6%, reflecting challenges in managing costs amidst fluctuating raw material prices. The net profit for FY 2024 was reported as a loss of ₹1 Cr, a troubling sign for investors, given that the company has not consistently turned a profit. The interest coverage ratio of 3.51x appears comfortable, suggesting that the company can meet its interest obligations despite the recent losses. However, the return on equity (ROE) is a mere 0.04%, and the return on capital employed (ROCE) at 7.12% raises concerns about the effectiveness of capital utilization. These figures hint at inefficiencies within operations that could hinder long-term profitability unless addressed promptly.
Balance Sheet Strength and Financial Ratios
The balance sheet reveals a somewhat precarious financial structure for Ambani Organics. With total borrowings at ₹61 Cr against reserves of ₹44 Cr, the debt-to-equity ratio of 1.05x suggests that the company is leveraging itself significantly, which could pose risks if earnings do not improve. The cash conversion cycle of -29 days indicates that the company is efficient in managing its working capital, meaning it converts its investments in inventory back into cash relatively quickly. However, the current ratio of 1.01x is barely above the threshold, reflecting limited liquidity. Furthermore, a price-to-book value ratio of 1.73x suggests that the stock is trading at a premium compared to its book value, which might deter value-oriented investors who often seek bargains in the market.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ambani Organics reveals a significant stake held by promoters, currently at 61.25%, which can be seen as a sign of confidence from the management. However, this level has fluctuated over recent years, indicating potential concerns regarding broader investor sentiment. The public holds 38.75% of the shares, which is a healthy proportion, but the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) could signal a lack of institutional backing. The number of shareholders has remained relatively stable, with 280 reported recently. While this stability is positive, the company must work to attract more institutional investment to bolster its credibility and provide a buffer against market volatility.
Outlook, Risks, and Final Insight
Looking ahead, Ambani Organics faces a dual-edged sword. On one hand, the company’s ability to increase sales in recent quarters suggests a potential for recovery, but persistent profitability issues may deter cautious investors. The high leverage and modest liquidity levels represent significant risks, especially in an economic environment where interest rates may fluctuate. Moreover, the lack of institutional investment could limit the stock’s upward momentum. Investors should closely monitor the company’s operational efficiency and cost management strategies, as these will be critical in determining its long-term viability. In conclusion, while there are signs of positive momentum, the risks associated with profitability and financial structure warrant a careful approach for potential investors considering Ambani Organics Ltd.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 99.9 Cr. | 280 | 456/255 | 232 | 392 | 0.04 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,342 Cr. | 9,261 | 14,250/8,150 | 53.1 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 35.4 Cr. | 118 | 329/109 | 17.5 | 26.9 | 0.85 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 317 Cr. | 396 | 435/163 | 17.6 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,630.08 Cr | 1,525.81 | 65.15 | 334.84 | 0.41% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 38 | 36 | 26 | 61 | 67 | 59 | 67 | 66 | 62 | 74 | 82 | 112 |
| Expenses | 39 | 35 | 33 | 24 | 57 | 64 | 55 | 64 | 61 | 58 | 74 | 77 | 106 |
| Operating Profit | 3 | 3 | 3 | 2 | 4 | 3 | 4 | 4 | 5 | 5 | 0 | 4 | 6 |
| OPM % | 8% | 7% | 8% | 9% | 7% | 5% | 7% | 5% | 7% | 8% | 0% | 5% | 6% |
| Other Income | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 5 | 0 | 0 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 3 | 4 | 4 | 3 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 1 | 1 | 1 | 0 | 2 | 1 | 2 | 1 | 2 | 0 | -0 | -1 | 2 |
| Tax % | 22% | 43% | 21% | 24% | 38% | 32% | 26% | 26% | 41% | 63% | -5,960% | 33% | 47% |
| Net Profit | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 3 | -2 | 1 |
| EPS in Rs | 1.99 | 1.14 | 1.59 | 0.71 | 2.64 | 1.46 | 1.97 | 1.35 | 1.73 | 0.16 | 4.15 | -2.52 | 1.21 |
Last Updated: August 5, 2025, 3:16 pm
Below is a detailed analysis of the quarterly data for Ambani Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 112.00 Cr.. The value appears strong and on an upward trend. It has increased from 82.00 Cr. (Sep 2024) to 112.00 Cr., marking an increase of 30.00 Cr..
- For Expenses, as of Mar 2025, the value is 106.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Sep 2024) to 106.00 Cr., marking an increase of 29.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Sep 2024) to 6.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Mar 2025, the value is 6.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Sep 2024) to 6.00%, marking an increase of 1.00%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Interest, as of Mar 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Sep 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 3.00 Cr..
- For Tax %, as of Mar 2025, the value is 47.00%. The value appears to be increasing, which may not be favorable. It has increased from 33.00% (Sep 2024) to 47.00%, marking an increase of 14.00%.
- For Net Profit, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from -2.00 Cr. (Sep 2024) to 1.00 Cr., marking an increase of 3.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.21. The value appears strong and on an upward trend. It has increased from -2.52 (Sep 2024) to 1.21, marking an increase of 3.73.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:40 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 52 | 65 | 79 | 73 | 87 | 125 | 132 | 136 | 193 | 223 |
| Expenses | 49 | 60 | 74 | 68 | 81 | 118 | 124 | 131 | 183 | 208 |
| Operating Profit | 3 | 5 | 6 | 5 | 6 | 6 | 8 | 5 | 9 | 14 |
| OPM % | 6% | 7% | 7% | 7% | 7% | 5% | 6% | 3% | 5% | 6% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 5 | 2 | 0 |
| Interest | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 7 | 8 | 8 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 |
| Profit before tax | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 0 | 0 | 3 |
| Tax % | 32% | 17% | 28% | 39% | 35% | 28% | 35% | -1,116% | 300% | |
| Net Profit | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | -1 | 1 |
| EPS in Rs | 2.10 | 4.64 | 3.41 | 2.72 | 3.35 | 3.12 | 3.08 | 4.31 | -1.11 | 1.46 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 0.00% | -50.00% | 100.00% | 0.00% | 0.00% | 50.00% | -133.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -100.00% | -50.00% | 150.00% | -100.00% | 0.00% | 50.00% | -183.33% |
Ambani Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 16% |
| TTM: | 42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 21% |
| 1 Year: | 43% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | -1% |
| Last Year: | -3% |
Last Updated: September 4, 2025, 11:00 pm
Balance Sheet
Last Updated: December 4, 2025, 12:56 am
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 7 | 8 | 13 |
| Reserves | 0 | 2 | 10 | 12 | 13 | 24 | 26 | 39 | 44 | 44 |
| Borrowings | 13 | 16 | 15 | 20 | 34 | 53 | 52 | 61 | 60 | 61 |
| Other Liabilities | 22 | 26 | 31 | 26 | 25 | 29 | 54 | 68 | 97 | 87 |
| Total Liabilities | 38 | 48 | 61 | 62 | 78 | 112 | 137 | 176 | 208 | 205 |
| Fixed Assets | 12 | 13 | 13 | 15 | 21 | 22 | 21 | 59 | 77 | 84 |
| CWIP | 0 | 0 | 0 | 2 | 0 | 9 | 47 | 8 | 7 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 26 | 35 | 48 | 46 | 56 | 80 | 69 | 109 | 124 | 121 |
| Total Assets | 38 | 48 | 61 | 62 | 78 | 112 | 137 | 176 | 208 | 205 |
Below is a detailed analysis of the balance sheet data for Ambani Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 44.00 Cr..
- For Borrowings, as of Sep 2025, the value is 61.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 60.00 Cr. (Mar 2025) to 61.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 87.00 Cr.. The value appears to be improving (decreasing). It has decreased from 97.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 10.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 205.00 Cr.. The value appears to be improving (decreasing). It has decreased from 208.00 Cr. (Mar 2025) to 205.00 Cr., marking a decrease of 3.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 84.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2025) to 84.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 121.00 Cr.. The value appears to be declining and may need further review. It has decreased from 124.00 Cr. (Mar 2025) to 121.00 Cr., marking a decrease of 3.00 Cr..
- For Total Assets, as of Sep 2025, the value is 205.00 Cr.. The value appears to be declining and may need further review. It has decreased from 208.00 Cr. (Mar 2025) to 205.00 Cr., marking a decrease of 3.00 Cr..
However, the Borrowings (61.00 Cr.) are higher than the Reserves (44.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.00 | -11.00 | -9.00 | -15.00 | -28.00 | -47.00 | -44.00 | -56.00 | -51.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 112 | 103 | 104 | 117 | 127 | 94 | 78 | 72 | 80 |
| Inventory Days | 53 | 70 | 95 | 102 | 92 | 75 | 77 | 100 | 103 |
| Days Payable | 129 | 131 | 134 | 100 | 81 | 63 | 142 | 194 | 213 |
| Cash Conversion Cycle | 35 | 42 | 65 | 118 | 138 | 105 | 13 | -22 | -29 |
| Working Capital Days | -8 | 3 | 31 | 42 | 36 | 17 | -14 | 20 | -29 |
| ROCE % | 22% | 20% | 15% | 12% | 9% | 9% | 2% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.11 | -12.80 | 1.07 | 3.06 | 3.35 |
| Diluted EPS (Rs.) | -2.11 | -12.80 | 1.07 | 3.06 | 3.35 |
| Cash EPS (Rs.) | 2.90 | 8.32 | 5.34 | 5.32 | 5.38 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 66.82 | 65.64 | 49.70 | 47.69 | 36.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 66.82 | 65.64 | 49.70 | 47.69 | 36.49 |
| Revenue From Operations / Share (Rs.) | 253.21 | 192.96 | 206.42 | 195.94 | 170.65 |
| PBDIT / Share (Rs.) | 14.10 | 7.23 | 13.51 | 11.51 | 12.99 |
| PBIT / Share (Rs.) | 10.08 | 3.23 | 11.24 | 9.31 | 10.96 |
| PBT / Share (Rs.) | 0.56 | -10.05 | 4.69 | 4.36 | 5.14 |
| Net Profit / Share (Rs.) | -1.12 | 4.31 | 3.07 | 3.13 | 3.35 |
| NP After MI And SOA / Share (Rs.) | -1.12 | 4.31 | 3.07 | 3.13 | 3.35 |
| PBDIT Margin (%) | 5.56 | 3.74 | 6.54 | 5.87 | 7.61 |
| PBIT Margin (%) | 3.98 | 1.67 | 5.44 | 4.75 | 6.42 |
| PBT Margin (%) | 0.22 | -5.20 | 2.27 | 2.22 | 3.01 |
| Net Profit Margin (%) | -0.44 | 2.23 | 1.48 | 1.59 | 1.96 |
| NP After MI And SOA Margin (%) | -0.44 | 2.23 | 1.48 | 1.59 | 1.96 |
| Return on Networth / Equity (%) | -1.67 | 6.56 | 6.18 | 6.55 | 9.18 |
| Return on Capital Employeed (%) | 8.95 | 2.74 | 10.23 | 10.50 | 16.54 |
| Return On Assets (%) | -0.41 | 1.73 | 1.43 | 1.79 | 2.18 |
| Long Term Debt / Equity (X) | 0.42 | 0.50 | 0.73 | 0.37 | 0.32 |
| Total Debt / Equity (X) | 1.05 | 1.19 | 2.09 | 1.54 | 1.70 |
| Asset Turnover Ratio (%) | 1.01 | 0.87 | 1.06 | 1.33 | 1.23 |
| Current Ratio (X) | 1.01 | 1.15 | 1.01 | 1.30 | 1.27 |
| Quick Ratio (X) | 0.67 | 0.83 | 0.66 | 0.91 | 0.86 |
| Inventory Turnover Ratio (X) | 5.51 | 4.29 | 5.17 | 5.06 | 4.34 |
| Interest Coverage Ratio (X) | 1.39 | 0.75 | 2.08 | 2.32 | 2.19 |
| Interest Coverage Ratio (Post Tax) (X) | 0.82 | 0.75 | 1.48 | 1.63 | 1.55 |
| Enterprise Value (Cr.) | 131.77 | 126.46 | 118.61 | 112.99 | 51.85 |
| EV / Net Operating Revenue (X) | 0.67 | 0.92 | 0.89 | 0.89 | 0.59 |
| EV / EBITDA (X) | 12.20 | 24.77 | 13.65 | 15.26 | 7.86 |
| MarketCap / Net Operating Revenue (X) | 0.45 | 0.53 | 0.39 | 0.56 | 0.26 |
| Price / BV (X) | 1.73 | 1.57 | 1.63 | 2.31 | 1.26 |
| Price / Net Operating Revenue (X) | 0.45 | 0.53 | 0.39 | 0.56 | 0.26 |
| EarningsYield | -0.01 | 0.04 | 0.03 | 0.02 | 0.07 |
After reviewing the key financial ratios for Ambani Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.11. This value is below the healthy minimum of 5. It has increased from -12.80 (Mar 24) to -2.11, marking an increase of 10.69.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.11. This value is below the healthy minimum of 5. It has increased from -12.80 (Mar 24) to -2.11, marking an increase of 10.69.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 3. It has decreased from 8.32 (Mar 24) to 2.90, marking a decrease of 5.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.82. It has increased from 65.64 (Mar 24) to 66.82, marking an increase of 1.18.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.82. It has increased from 65.64 (Mar 24) to 66.82, marking an increase of 1.18.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 253.21. It has increased from 192.96 (Mar 24) to 253.21, marking an increase of 60.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 14.10. This value is within the healthy range. It has increased from 7.23 (Mar 24) to 14.10, marking an increase of 6.87.
- For PBIT / Share (Rs.), as of Mar 25, the value is 10.08. This value is within the healthy range. It has increased from 3.23 (Mar 24) to 10.08, marking an increase of 6.85.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.56. This value is within the healthy range. It has increased from -10.05 (Mar 24) to 0.56, marking an increase of 10.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.12. This value is below the healthy minimum of 2. It has decreased from 4.31 (Mar 24) to -1.12, marking a decrease of 5.43.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -1.12. This value is below the healthy minimum of 2. It has decreased from 4.31 (Mar 24) to -1.12, marking a decrease of 5.43.
- For PBDIT Margin (%), as of Mar 25, the value is 5.56. This value is below the healthy minimum of 10. It has increased from 3.74 (Mar 24) to 5.56, marking an increase of 1.82.
- For PBIT Margin (%), as of Mar 25, the value is 3.98. This value is below the healthy minimum of 10. It has increased from 1.67 (Mar 24) to 3.98, marking an increase of 2.31.
- For PBT Margin (%), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 10. It has increased from -5.20 (Mar 24) to 0.22, marking an increase of 5.42.
- For Net Profit Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 5. It has decreased from 2.23 (Mar 24) to -0.44, marking a decrease of 2.67.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 8. It has decreased from 2.23 (Mar 24) to -0.44, marking a decrease of 2.67.
- For Return on Networth / Equity (%), as of Mar 25, the value is -1.67. This value is below the healthy minimum of 15. It has decreased from 6.56 (Mar 24) to -1.67, marking a decrease of 8.23.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.95. This value is below the healthy minimum of 10. It has increased from 2.74 (Mar 24) to 8.95, marking an increase of 6.21.
- For Return On Assets (%), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 5. It has decreased from 1.73 (Mar 24) to -0.41, marking a decrease of 2.14.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.50 (Mar 24) to 0.42, marking a decrease of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.05. This value exceeds the healthy maximum of 1. It has decreased from 1.19 (Mar 24) to 1.05, marking a decrease of 0.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has increased from 0.87 (Mar 24) to 1.01, marking an increase of 0.14.
- For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has decreased from 1.15 (Mar 24) to 1.01, marking a decrease of 0.14.
- For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.83 (Mar 24) to 0.67, marking a decrease of 0.16.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.51. This value is within the healthy range. It has increased from 4.29 (Mar 24) to 5.51, marking an increase of 1.22.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 24) to 1.39, marking an increase of 0.64.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 24) to 0.82, marking an increase of 0.07.
- For Enterprise Value (Cr.), as of Mar 25, the value is 131.77. It has increased from 126.46 (Mar 24) to 131.77, marking an increase of 5.31.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.67, marking a decrease of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 12.20. This value is within the healthy range. It has decreased from 24.77 (Mar 24) to 12.20, marking a decrease of 12.57.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has decreased from 0.53 (Mar 24) to 0.45, marking a decrease of 0.08.
- For Price / BV (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.57 (Mar 24) to 1.73, marking an increase of 0.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has decreased from 0.53 (Mar 24) to 0.45, marking a decrease of 0.08.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to -0.01, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambani Organics Ltd:
- Net Profit Margin: -0.44%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.95% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -1.67% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.82
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 128 (Industry average Stock P/E: 65.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -0.44%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | N-44, MIDC Tarapur, Boisar, Thane Maharashtra 401506 | info@ambaniorganics.com http://www.ambaniorganics.com |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Apooni R Shah | Chairman & Wholetime Director |
| Mr. Rakesh H Shah | Managing Director |
| Mr. Bhavin Jitendra Patel | Ind. Non-Executive Director |
| Mr. Neerajkumar A Pandey | Ind. Non-Executive Director |
| Mr. Sanjay N Mehta | Independent Director |
| Dr. Prakash A Mahanwar | Independent Director |
FAQ
What is the intrinsic value of Ambani Organics Ltd?
Ambani Organics Ltd's intrinsic value (as of 19 December 2025) is 3.11 which is 97.04% lower the current market price of 105.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 80.4 Cr. market cap, FY2025-2026 high/low of 148/96.2, reserves of ₹44 Cr, and liabilities of 205 Cr.
What is the Market Cap of Ambani Organics Ltd?
The Market Cap of Ambani Organics Ltd is 80.4 Cr..
What is the current Stock Price of Ambani Organics Ltd as on 19 December 2025?
The current stock price of Ambani Organics Ltd as on 19 December 2025 is 105.
What is the High / Low of Ambani Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ambani Organics Ltd stocks is 148/96.2.
What is the Stock P/E of Ambani Organics Ltd?
The Stock P/E of Ambani Organics Ltd is 128.
What is the Book Value of Ambani Organics Ltd?
The Book Value of Ambani Organics Ltd is 74.5.
What is the Dividend Yield of Ambani Organics Ltd?
The Dividend Yield of Ambani Organics Ltd is 0.00 %.
What is the ROCE of Ambani Organics Ltd?
The ROCE of Ambani Organics Ltd is 7.12 %.
What is the ROE of Ambani Organics Ltd?
The ROE of Ambani Organics Ltd is 0.04 %.
What is the Face Value of Ambani Organics Ltd?
The Face Value of Ambani Organics Ltd is 10.0.